StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Aristotle has finally launched...

<< Previous

Bullboard Posts

Next >>

Comment by johnny007on Jul 08, 2021 10:22am

103 Views

Post# 33511616

RE:RE:Aristotle has finally launched...

Same page work on Stagezero's website though, incl. the employer info.

https://www.stagezerolifesciences.com/aristotle-test.html
https://www.stagezerolifesciences.com/aristotle.html
- Submit works
- Employer works

https://www.stagezerolifesciences.com/employers.html
- Employer AVRT Aristotole site

+++

https://careoncology.com/aristotle/
- Submit works
- Employer disabled

+++

in the meantime, stock gets even cheaper :)

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments